325 related articles for article (PubMed ID: 27119456)
21. Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer's Disease.
Han J; Lee HJ; Kim KY; Lee SJC; Suh JM; Cho J; Chae J; Lim MH
ACS Chem Neurosci; 2018 Apr; 9(4):800-808. PubMed ID: 29283241
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
23. Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.
Hamulakova S; Poprac P; Jomova K; Brezova V; Lauro P; Drostinova L; Jun D; Sepsova V; Hrabinova M; Soukup O; Kristian P; Gazova Z; Bednarikova Z; Kuca K; Valko M
J Inorg Biochem; 2016 Aug; 161():52-62. PubMed ID: 27230386
[TBL] [Abstract][Full Text] [Related]
24. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
[TBL] [Abstract][Full Text] [Related]
25. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
26. Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation.
Oliveri V; Bellia F; Pietropaolo A; Vecchio G
Chemistry; 2015 Sep; 21(40):14047-59. PubMed ID: 26298549
[TBL] [Abstract][Full Text] [Related]
27. Strategies Employing Transition Metal Complexes To Modulate Amyloid-β Aggregation.
Suh JM; Kim G; Kang J; Lim MH
Inorg Chem; 2019 Jan; 58(1):8-17. PubMed ID: 30556393
[TBL] [Abstract][Full Text] [Related]
28. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
29. Reactivity of Metal-Free and Metal-Associated Amyloid-β with Glycosylated Polyphenols and Their Esterified Derivatives.
Korshavn KJ; Jang M; Kwak YJ; Kochi A; Vertuani S; Bhunia A; Manfredini S; Ramamoorthy A; Lim MH
Sci Rep; 2015 Dec; 5():17842. PubMed ID: 26657338
[TBL] [Abstract][Full Text] [Related]
30. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
31. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
32. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
[TBL] [Abstract][Full Text] [Related]
33. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
34. Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species.
He X; Park HM; Hyung SJ; DeToma AS; Kim C; Ruotolo BT; Lim MH
Dalton Trans; 2012 Jun; 41(21):6558-66. PubMed ID: 22437427
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach.
Simoni E; Serafini MM; Caporaso R; Marchetti C; Racchi M; Minarini A; Bartolini M; Lanni C; Rosini M
ACS Chem Neurosci; 2017 Jul; 8(7):1618-1627. PubMed ID: 28421738
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease.
Xie S; Chen J; Li X; Su T; Wang Y; Wang Z; Huang L; Li X
Bioorg Med Chem; 2015 Jul; 23(13):3722-9. PubMed ID: 25934229
[TBL] [Abstract][Full Text] [Related]
37. N
Zhang W; Liu Y; Hureau C; Robert A; Meunier B
Chemistry; 2018 Jun; 24(31):7825-7829. PubMed ID: 29687932
[TBL] [Abstract][Full Text] [Related]
38. Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides.
Liu L; Xia N
Biochem Biophys Res Commun; 2012 Jan; 417(1):153-6. PubMed ID: 22138653
[TBL] [Abstract][Full Text] [Related]
39. Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand.
Nguyen M; Bijani C; Martins N; Meunier B; Robert A
Chemistry; 2015 Nov; 21(47):17085-90. PubMed ID: 26420347
[TBL] [Abstract][Full Text] [Related]
40. Naturally Inspired Molecules as Multifunctional Agents for Alzheimer's Disease Treatment.
Rampa A; Tarozzi A; Mancini F; Pruccoli L; Di Martino RM; Gobbi S; Bisi A; De Simone A; Palomba F; Zaccheroni N; Belluti F
Molecules; 2016 May; 21(5):. PubMed ID: 27196880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
